Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C8H10AsN2O4.2Na.H2O |
Molecular Weight | 610.19 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Na+].[Na+].NC(=O)CNC1=CC=C(C=C1)[As](O)([O-])=O.NC(=O)CNC2=CC=C(C=C2)[As](O)([O-])=O
InChI
InChIKey=CGSBXNNKDCWLRS-UHFFFAOYSA-L
InChI=1S/2C8H11AsN2O4.2Na.H2O/c2*10-8(12)5-11-7-3-1-6(2-4-7)9(13,14)15;;;/h2*1-4,11H,5H2,(H2,10,12)(H2,13,14,15);;;1H2/q;;2*+1;/p-2
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C8H10AsN2O4 |
Molecular Weight | 273.0976 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tryparsamide is an arsenic compound with activity against Spirochaetes bacteria. Tryparsamide is used in the treatment of syphilis and African sleeping sickness. For decades Tryparsamide remained the standard treatment for trypanosomiasis. Tryparsamide has two remarkable properties: first, it increases the resistance of the individual by improving his general physical status; and, second, the high penetrability for nervous tissue which it possesses may increase the potential spirocheticidal action of the drug.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Tryparsamide Therapy of Neurosyphilis in Negroes. | 1931 Jul |
|
General Discussion on Tryparsamide and Stovarsol: Meeting of The Medical Society for the Study of Venereal Diseases. London. July 13th, 1940. | 1941 Jan |
|
The present status of tryparsamide in syphilotherapy. | 1947 May |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20315250
The proper dosage for the average individual is to 3 grams of the drug. This amount dissolved in 10-20 cc. of sterile distilled water is given weekly. It may be given subcutaneously, intramuscularly or intravenously. The intravenous route is the preferable one to use. It should be given slowly by the syringe method.
Route of Administration:
Parenteral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:36:25 GMT 2023
by
admin
on
Sat Dec 16 09:36:25 GMT 2023
|
Record UNII |
38892Q01QB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6159-29-1
Created by
admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
|
PRIMARY | |||
|
38892Q01QB
Created by
admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
|
PRIMARY | |||
|
91618135
Created by
admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
|
PRIMARY | |||
|
DTXSID101333778
Created by
admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
|
PRIMARY | |||
|
m11244
Created by
admin on Sat Dec 16 09:36:26 GMT 2023 , Edited by admin on Sat Dec 16 09:36:26 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |